Delcath Appoints Gastroenterologist Dr. Gregory Gores to Medical Advisory Board

Delcath Systems, a development stage specialty pharmaceutical and medical device company focused on oncology, has appointed Gregory Gores, MD, the Reuben R. Eisenberg Endowed Professor in gastroenterology and hepatology, professor of medicine and chair of the division of gastroenterology and hepatology at the Mayo Clinic in Rochester, Minn., to its medical advisory board, according to a news release.

"As a widely respected hepatologist and 2011 President of the International Liver Cancer Association, Dr. Gores will contribute a wealth of clinical knowledge on hepatotoxicity and drug induced liver pathology to our Medical Advisory Board," said Eamonn P. Hobbs, CEO and president of Delcath Systems in the release. "His insight will help provide valuable support to the commercialization of the Delcath Hepatic CHEMOSAT Delivery System in Europe and the rest of the world, as well as to our regulatory process in the United States."

Dr. Gores' research focuses on the basic mechanisms behind cell death in the liver and employing models to human disease. He has published more than 400 articles, chapters, reviews and editorials. Dr. Gores serves on the editorial boards for the American Journal of Physiology, American Journal of Gastroenterology and Nature Reviews in Clinical Gastroenterology and Hepatology.

Related Articles on Gastroenterology:

ASGE Recognizes 27 Endoscopy Units for Quality and Safety
Racial Disparity of Colorectal Cancer Mortality Rates Increased in Last 20 Years
Narrow Band Imaging Does Not Affect Detection Rate or Miss Rate in Colonoscopy

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers

Featured Podcast